Metabolic Health

Paul Saladino LDL, ApoB, and LMHR Risk Framing

TG down and HDL up do not cancel extreme ApoB. Measure; do not reassure by vibe.

BY MARCUS CHEN 4 MIN READ 3 SOURCES

Editorial still life for paul saladino ldl apob lmhr, no people — Illustration: Health Canon

In short

Carnivore and very-low-carb animal-heavy patterns frequently raise LDL-C and ApoB (Lennerz subset median LDL ~172 mg/dL) while TG fall and HDL rises. LMHR shows extreme LDL on carb restriction. Mainstream prevention treats ApoB/LDL as causal risk markers; high-LDL-is-benign-in-context claims remain unproven for hard outcomes.

Marker discordance is not moral victory. Show the full panel.

This article is informational and editorial only. It is not medical advice, diagnosis, or a treatment plan. Numbers and literature ranges cited here are not personal prescriptions. Consult a qualified clinician before changing medications, supplements, diet, equipment, or management of a diagnosed condition. Seek urgent care for emergencies.

What did the Lennerz survey show—and not show?

n≈2029 self-selected carnivore adults, median age 44, majority male, median duration about 14 months, high self-reported satisfaction. Among those reporting lipids, LDL was markedly elevated with higher HDL and lower TG patterns in secondary summaries.

Online survey survivor bias underestimates harm and overestimates benefit. Not randomized; not hard-outcome proof of safety.

How does LMHR change the conversation?

Lean people in deep ketosis can show extreme LDL with high HDL and low TG. Carb titration experiments can test LDL responsiveness. Fruit-inclusive animal-based patterns may moderate ketosis-driven LMHR magnitude for some—hypothesis grade C; measure, do not assume.

Key reference points
Metric	Reported figure
Lennerz median LDL (subset)	~172 mg/dL
Survey n	2029
Male share	~67%
Hard-outcome RCT of carnivore	None adequate
ApoB as risk marker (general)	High confidence

What does mainstream risk science say about ApoB?

Cumulative ApoB exposure drives atherosclerosis in the broader genetic and pharmacologic evidence base. Extreme LDL for years is not a free lunch pending definitive LMHR outcome trials. Plaque imaging studies in high-LDL keto groups are evolving and contested—insufficient for long-term safety claims.

What practical rules apply?

Baseline plus follow-up lipids/ApoB for anyone adopting animal-based or carnivore eating. Do not reassure extreme LDL with TG/HDL alone. Refer established ASCVD or FH phenotypes before high-SFA animal diets. Document lean + high LDL as research context, not proof of safety.

Sources: Lennerz carnivore survey; Norwitz LMHR context; Norwitz LMHR elevated LDL.

Readers should dual-source primary literature, translate slogans into exposure units and effect sizes, and rank interventions by expected value under uncertainty. Cheap reversible steps often outrank extreme protocols. Opportunity cost is real: hours spent on unvalidated tests are hours not spent on sleep, training, protein adequacy, and primary care. Sex, life stage, comorbidities, medications, and geography change interpretation. Prefer falsifiable claims with named endpoints over multi-disease cure lists. Update beliefs when stronger trials appear rather than freezing identity around a single paper or influencer narrative. Measured curiosity beats both panic and complacency. Further reading should prioritize primary sources and consensus documents over secondary social summaries. When evidence is mixed, state both the signal and the limits in the same paragraph. When evidence is strong, still avoid overclaiming universality across populations.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Sources & citations

Frequently asked

Questions & answers

What happens to cholesterol on carnivore or animal-based diets?

Very-low-carb animal-heavy patterns frequently produce higher LDL-C and ApoB, sometimes marked, while triglycerides fall and HDL rises. Lennerz et al. (2021) reported a subset median LDL around 172 mg/dL among self-selected carnivore adults reporting lipids. That is an association in a survey, not a randomized trial.

What is the lean mass hyper-responder phenotype?

LMHR describes lean individuals on ketogenic or very-low-carb diets who develop very high LDL-C with high HDL and low triglycerides. Carb reintroduction can lower LDL in this phenotype for some people—mechanistically relevant to fruit-inclusive animal-based approaches. Extreme LDL for years is not automatically safe pending outcome trials.

Can low triglycerides cancel high LDL?

No. Improving TG/HDL while ApoB worsens is a mixed card. Mainstream prevention uses ApoB or LDL as causal risk markers supported by genetic and pharmacologic evidence. Influencer claims that high LDL is benign in context remain unproven for hard outcomes. Do not reassure extreme LDL with TG/HDL alone.

Should everyone get imaging if LDL is high on keto?

Imaging such as coronary artery calcium is a shared decision in selected high-LDL long-duration cases, not a universal mandate or a free pass when CAC is zero at a young age. Family history, familial hypercholesterolemia phenotypes, and baseline ASCVD change urgency. Clinicians individualize.

What labs should people track if adopting animal-based eating?

Baseline and follow-up lipids with ApoB when available, non-HDL cholesterol, triglycerides, HDL, and Lp(a) once. Do not skip labs because you feel amazing. Refer established ASCVD or FH phenotypes before high-saturated-fat animal diets without medical oversight. This is general editorial context, not individualized medical advice; match decisions to clinical care when stakes are high.